Hosted on MSN18d
Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?
Amgen has initiated two “critical” late-stage trials for its experimental weight loss injection, MariTide. MariTide is a monthly injection designed to compete with existing weekly GLP-1 weight-loss ...
Which Dow Jones Stock Is Cheaper, Amgen or Merck?
Based on Wall Street analyst estimates for 2025 EPS, Amgen trades at 15 times its projected earnings, while Merck sits at a ...
2 Surefire Dividend Stocks That Could Pay You for Life
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
NBC Washington26d
Amgen starts two critical late-stage trials for weight loss drug MariTide
Amgen said it has started two critical late-stage trials for its experimental weight loss injection, MariTide, another step in its bid to enter the booming obesity drug market. MariTide is a ...
Seeking Alpha21d
Amgen: Riding The MariTide Of Monthly Weight Loss
Amgen Inc.'s stock has surged 13% recently, likely due to promising developments with its obesity injection, MariTide, which offers unique benefits over current treatments. MariTide's dual ...